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A B S T R A C T
Transvenous lead extraction (TLE) of the Starﬁx coronary sinus (CS) active-ﬁxation lead may be
challenging, due to undeployment of ﬁxation lobes and venous occlusion. We report our experience in
Starﬁx TLE, in comparison with previous data.
A 78-year-old male, implanted in 2009 with Starﬁx lead, was referred to our institution for TLE, due to
infective endocarditis with lead-associated vegetations. The tip of Starﬁx lead was located in distant,
anterior position, in the great cardiac vein, close to patent left internal mammary artery-to-left anterior
descending artery anastomosis, and ﬁrst-choice surgical removal had a prohibitive operative risk.
Conventional dilatation beyond CS ostium, as well as the use of a standard delivery catheter, was
ineffective. An off-label modiﬁcation of the delivery, by cutting the distal soft tip, was successful.
However, the tip of the lead fragmented and was trapped in the innominate vein. Then a gooseneck snare
grasped the fragment, allowing complete retrieval.
TLE of Starﬁx leads may be particularly challenging, especially when its tip is located in a distant anterior
location. In these cases, important help may be obtained by dilatation within the CS, by means of
conventional or modiﬁed delivery catheters. Only experienced operators, sometimes with non-
conventional techniques, should perform TLE of Starﬁx leads.
<Learning objective: TLE of Starﬁx leads may be challenging, particularly when the tip is located in a
distant anterior position. Dilatation with conventional tools may be precluded. In these cases
modiﬁcations of the delivery catheters may be useful. Surgery should be avoided as ﬁrst-choice
procedure; only experienced operators, sometimes with non-conventional techniques, should perform
TLE of Starﬁx leads.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Implantation of left ventricular (LV) leads through coronary
sinus (CS) may be challenging. The general cardiologist, indeed,
should also be acquainted with the stability issues of the leads used
for resynchronization and to the difﬁculties and risks related to the
extraction of active-ﬁxation coronary sinus leads.
Dislodgements of LV leads account for 4–10% of cases, with
threshold worsening, loss of capture, phrenic nerve stimulation,
and inadequate cardiac resynchronization therapy (CRT). Technol-
ogy improvements were developed to maintain adequate stability,
and active ﬁxation leads were introduced (Attain Starﬁx OTW LV* Corresponding author at: Division of Cardiology, Department of Internal Medicine,
Azienda Ospedaliero-Universitaria Citta` della Salute e della Scienza di Torino,
Corso A. M. Dogliotti, 14, 10126 Torino, Italy. Tel.: +39 0116636165/3332274241;
fax: +39 0116967053.
E-mail addresses: pg.golzio@gmail.com, pgolzio@cittadellasalute.to.it,
piergiorgio.golzio@unito.it (P.G. Golzio).
http://dx.doi.org/10.1016/j.jccase.2015.09.004
1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsLead, Model 4195, Medtronic, Minneapolis, MN, USA) (Fig. 1). First
experience with such leads was reported in 2007 [1], with only
0.7% dislodgement rates at 2-year follow-up [2], and improved
success rate of CRT. However, the difﬁculty of using such LV active
ﬁxation leads was conﬁrmed, particularly with respect to
transvenous lead extraction (TLE), even in recently implanted
leads [1,2].
Case report
A 78-year-old male patient was referred to our institution for
TLE, due to pocket infection with lead-associated vegetations.
In 1991 the patient suffered inferior myocardial infarction and
underwent surgical revascularization with left internal mammary
artery (LIMA) anastomization to left anterior descending (LAD). In
2009, due to depressed ejection fraction with inducible ventricular
tachycardia, he was implanted with single chamber implantable
cardioverter-deﬁbrillator; a double coil passive ﬁxation shock lead
was used (Sprint Quattro, Model 6944, Medtronic Inc.). From reserved.
Fig. 1.
Technical representation of the Starﬁx lead, with ﬁxation lobes undeployed and deployed. Considering the anatomy of the coronary sinus, understanding how the
ﬁxation mechanism acts, and how deployed ﬁxation lobes can cause occlusion of the coronary sinus, is easily allowed. Fibrosis and adherences can further ensue,
so making lead extraction very risky and difﬁcult. You can see the steroid-eluting tip (Panel A, 1), followed by three series of four polyurethane lobes each (A, 2).
They can be deployed by advancing the push tubing along the lead (A, 3), so increasing the external diameter from the 5-French caliber of the lead body (A, 4) up to
up to 24-French. Four radiopaque platinum–iridium indicator rings (Panel B, 5) on each side of the series of lobes can be seen under ﬂuoroscopy to mark the extent
of lobe undeployment (Panel C, 5a) and deployment (Panel C, 5b). Also shown in scheme, Panel A: standard ﬁxation sleeve (6), lead sewing sleeve (7) and IS-1
unipolar connector (8). Panel B shows schematic representation of progressive deployment of ﬁxation lobes, and Panel C the scheme of the Starﬁx lead within the
target venous branch of the coronary sinus, immediately after attainment of the target vein, with lobes undeployed (5a, ﬂuoro scheme within the circle) and
deployed (5b, ﬂuoro scheme within the circle). The pullback of the tubing should be able to undeploy lobes, but frequent drawbacks occur, due to failure of the
mechanism itself, and/or ﬁbrosis within and around lobes.
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dehiscence, with exposure of the can and lead. The absence of
systemic involvement was accepted, by the referring physicians
and in contrast to expert consensus [3], as warranting two local
repair procedures, ﬁrst with relocation of the exposed lead and
pulse generator, and then with generator replacement and
preservation of the lead. Even so, due to worsened heart failure
with left bundle branch block, in November 2011 the device was
upgraded to biventricular (Concerto II CRTD D 294 TRK, Med-
tronic), with only a new LV lead for permanent atrial ﬁbrillation.
Lateral and postero-lateral CS branches were not suitable for
implantation, and stability issues resulted in the choice of an active
ﬁxation lead (Attain Starﬁx LV OTW Lead, Model 4195, Medtronic
Inc.), which was anteriorly located in the mid-portion of the great
cardiac vein (GCV). The procedure was complicated by pocket
hematoma, requiring surgical revision 1 month later. In June 2014,
new skin erosion was evident, with further exposure of one lead.
Transesophageal echocardiography disclosed ﬁliform images
along the transatrial segment of both right ventricular and CS
leads, ﬁnally and clearly convincing the colleagues of the need for
TLE.
After admission to our center, coronary angiography showed
proximal occlusion of the native coronary arteries, with myocar-
dial perfusion due completely to a patent LIMA-to-LAD anastomo-
sis. Myocardial perfusion single-photon emission computed
tomography disclosed a wide irreversible infero-lateral defect,
and a small partially reversible apical defect. Therefore, the only
viable myocardial tissue was located in the anterior position,
perfused through the LIMA-to-LAD graft.Cardiac surgeons excluded surgical lead extraction as ﬁrst-
choice procedure, due to expected difﬁculty and risk of removing a
lead implanted in close proximity with a working LIMA-to-LAD
anastomosis (Fig. 2, Panel A).
TLE was performed under local anesthesia in the electrophysi-
ology laboratory, with a cardiac surgery team on active duty and
with support of an anesthesiologist and his equipment.
First, the Sprint Quattro lead was extracted with conventional
polypropylene Byrd mechanical dilators (Cook Vascular Inc.,
Vandergrift, PA, USA), up to the 11.5-French inner XL ‘‘white’’
one. A subsequent selective retrograde CS venography disclosed an
occlusion at the mid portion of the main CS (Fig. 2, Panel B). The LV
lead was cut, and a long standard CS stylet (Model 6054, 0.01600,
110 cm, Medtronic) was inserted and secured with ties. Advancing
the push tubing of the Starﬁx along the lead body resulted in a
partial undeployment of the proximal lobes only. A manual
traction attempt was ineffective; therefore, dilatation was
performed along the LV lead using the inner 7.0-French and 8.5-
French XL Byrd dilators, with the bevel stopping immediately after
CS entrance. A 57-cm long 7-French CS delivery (Attain Command
CS Cannulation Catheter, Model 6250VI-57S, Medtronic) was
advanced over the LV lead near the origin of the GCV (Fig. 2, Panel
C; Video 1). Then the soft tip collar of the delivery was cut [4], in
order to produce a greater pushing force along the lead. This off-
label modiﬁed delivery was able to reach the proximal series of the
ﬁxation lobes, resulting in their further undeployment (Fig. 2,
Panel D; Video 1). The distal end of this modiﬁed delivery was
ﬁrmly anchored to the proximal lobes, allowing repeated traction
to be effective in extracting the lead from the CS (Video 1). During
Fig. 2.
Panel A: coronary angiography. Selective angiography of left internal mammary artery (LIMA). LIMA-to-left anterior descending artery anastomosis is patent, and
well working. This anastomosis ensures the perfusion to the viable myocardium, since proximal interventricular, circumﬂex, and right coronary arteries are
occluded. This patient suffered an inferior myocardial infarction in 1991; myocardial perfusion with 99mTc-methoxyisobutylisonitrile stress/rest single-photon
emission computed tomography disclosed a wide irreversible inferior and infero-lateral defect, and a small partially reversible apical defect. Panel B: selective
retrograde coronary sinus (CS) venography, with a balloon-occluding Swan-Ganz catheter. The CS is cannulated through a conventional straight 50-cm long
7-French CS delivery (Attain Command CS Cannulation Catheter, Model 6250V-50S, Medtronic). After inﬂation of the Swan-Ganz balloon, occlusion of the mid
coronary sinus is observed. Panel C: a 57-cm long 7-French straight CS delivery (Attain Command CS Cannulation Catheter, Model 6250VI-57S, Medtronic) is
advanced over the left ventricular lead. The distal portion of the CS is reached, just before the angulation of the CS into the interventricular grove. This obtains a
partial undeployment of the proximal series of ﬁxation lobes. Panel D: off-label modiﬁcation of the delivery, by cutting the soft distal collar of the catheter. The
modiﬁcation produces a greater pushing force along the lead, so reaching the origin of the great cardiac vein. The distal end of this modiﬁed delivery is ﬁrmly
anchored to the proximal lobes.
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ﬁxation lobes deployed, not protected inside a dilator, was trapped
in the proximal innominate vein, immediately before the costo-
clavicular angle narrowing. Manual traction resulted in fragmen-
tation of the lead, with its tip retained, and consequent occlusion of
the vein (Fig. 3, Panel A). A LassosTM snare catheter, 908 loop angle,
30 mm loop diameter (OSYPKA AG, D-79618 Rheinfelden-Herten,
Germany) was unsuccessful in catching the lead fragment. A 0.02500
J Tip PTFE guide wire (Medtronic Inc.), driven by a 7-French MPA
1 guiding catheter (Cordis Corp., Miami Lakes, FL, USA), could pass
through the occlusion, and the lead tip was partially freed. An
Amplatz Goose Neck 6-French snare catheter, with a 30 mm loop
snare (ev3 Inc., Plymouth, MN, USA), was then used to grasp the tip
(Fig. 3, Panels B–D; Video 2), thereby allowing complete retrieval ofthe tip fragment through a 18-French long femoral sheath (Cook
Vascular) (Fig. 3, Panels E and F; Video 2). Subsequent course was
uneventful. In particular, no pericardial effusion was observed.
Supplementary Videos 1 and 2 related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.jccase.
2015.09.004.
Discussion
Extraction in chronic draining sinus-local infection at the device
pocket
This case shows that in patients with cardiac implanted
electronic devices and recurrent local problems at the device
Fig. 3.
Panel A: during extraction, the tip of the Starﬁx, not protected inside a dilator, is trapped into the innominate vein, just before the costo-clavicular angle
narrowing. Manual traction results in fragmentation of the lead, with its tip retained. Due to the traction forces carried out, the ﬁxation lobes are forced against
the vessel wall, and again fully deployed, so causing venous occlusion. Panels B and C: an Amplatz Goose Neck 6-French snare catheter, with a 30 mm loop snare
(ev3 Inc., Plymouth, MN, USA) catches the tip of the Starﬁx lead. Panel D: the traction over the tip undeploys the lobes, as can be seen at the mid innominate vein
level. Panel E: the tip fragment of the Starﬁx lead is extracted through a long 18-French femoral sheath. Panel F: the tip Starﬁx fragment extracted.
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infection should always be suspected. The Expert Consensus of the
Heart Rhythm Society (HRS) [3] recognizes as Level 1, Class of
evidence B, that complete device and lead removal is recom-
mended in all patients with pocket infection as evidenced by
pocket abscess, device erosion, skin adherence, or chronic draining
sinus without clinically evident involvement of the transvenousportion of the lead system. So the HRS Expert Consensus equalizes,
as a therapeutic key aspect, the chronic draining sinus/pocket
infection to infective involvement of the entire device system, thus
requiring TLE. This agrees with general experience and our own
data [4,5]. Moreover, in this case the infective involvement of
transvenous leads was further demonstrated by the subsequent
growing of intracardiac vegetations. Therefore, TLE should have
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delayed approach, due to the well-known hazard of TLE due to
active ﬁxation coronary sinus leads.
Extraction of the Starﬁx lead
The extraction of the Attain Starﬁx lead clearly can be
particularly challenging, even with recently implanted leads
[1]. Previous experiences of Starﬁx TLE are reported in Table 1,
with regard to dwelling time, implant site, undeployment of
ﬁxation lobes, technique used, and progression of sheaths within
the main CS, beyond CS entrance, or its branches. Only prospective
cases of Starﬁx lead extraction are considered, sorted out on an
intention-to-treat basis. Repositioning and implant revisions were
not taken into account. Retrospective analyses of larger studyTable 1 Experiences in TLE of Starﬁx lead.
Studya Pt # Indication to TLE Timeb Implant
sitec
Undeployment
of ﬁxation lobes
Crossley,
2010 [2]
1 Pocket erosion 478 NA No 
2 Loss of capture 546 NA Yes, proximal
or completed
3 Lead fracture 795 NA Y, proximal
or complete
4 NA 889 NA NA 
5 Systemic infection 910 NA No 
6 Lead fracture 941 NA Y, proximal
or complete
Luedorff,
2010 [11]
7 Perforation 180 NA NA 
8 Systemic infection 450 NA NA 
Williams,
2011 [10]
9 Systemic infection NA PL Yes, proximal
only
Bongiorni,
2011 [6]
10 Systemic infection 330 PL Yes, proximal
only
Curnis,
2012 [9]
11 Systemic infection 597 ANT-LAT No 
Maytin,
2012 [8]
12 Systemic infection 69 NA No 
13 Systemic infection 270 NA No 
14 Local infection 312 NA No 
15 Systemic infection 330 NA No 
16 Local infection 429 NA Yes, partially 
17 Systemic infection 486 NA Yes 
18 CRT failure 510 NA Yes, partially 
Maytin,
2012 [8]
19 Local infection 540 NA No 
20 Systemic infection 498 NA No 
21 Systemic infection 708 NA No 
Cronin,
2013 [7]
22 Systemic infection 392 NA Yes, proximal
only
23 Systemic infection 811 NA Yes, proximal
only
24 Systemic infection 1029 NA No 
25 Systemic infection 885 NA Yes, proximal
only
Kypta,
2014 [12]
26 Systemic infection NA LAT No 
CS, coronary sinus; COMPL, complications; NA, not assessed; PL, posterolateral site; ANT
TF, transfemoral; FWS, femoral workstation; TLE, transvenous lead extraction; LLD, lea
a Only cases with intention-to-treat indication to TLE are considered. Repositioning a
Expert Consensus (see text).
b Dwelling time of the Starﬁx lead in days.
c Implant site as described by the Authors, or gathered from presented images.
d Undeployment of ﬁxation lobes unspeciﬁed, involving only proximal or all lobes.populations are not considered, when not speciﬁcally aiming to
deﬁne results of Starﬁx lead extraction. Moreover, TLE was deﬁned
according to HRS Expert Consensus [3]. Dwelling time of extracted
Starﬁx leads was 599.1  271.1 days (range 69–1029). The Starﬁx
tip, as referred by the Authors or as could have been gathered from the
analysis of the published images, was located in a posterolateral,
lateral, or anterolateral position. The bevel of the dilators could reach
the main CS in 15 out of 19 patients, where information could have
been gained, and a CS branch only in 7. Undeployment of ﬁxation
lobes was frequently prevented [2,7–10], often occurring only with
proximal ones [6–9]. Such a mechanism may be responsible for acute
failures in extracting leads, while chronic venous occlusion, due to
reduction and slowing of blood ﬂow with consequent thrombosis,
may collaborate with worsening effect. The success rate for Starﬁx
TLE is approximately 73%, clearly below the 96–98% reported rate forTLE tools –
technique
Sheath
into CS
Sheath
into
branch
Outcome COMPL
Traction alone NA NA Failure 0
Traction alone NA NA Failure 0
Traction alone NA NA Failure 0
Traction alone NA NA Failure 0
Sheath + laser NA NA Success 0
Sheath + laser NA NA Success 0
Traction alone NA NA Success 0
Traction alone NA NA Success 0
Sheath + 12F laser Proximal CS No Failure Lead
fractured
tip left
7F Mech, Attain
8F Command
Mech dilator
into proximal CS
Yes, Attain
Command
Success 0
8.5F Mech, ablation
catheter (TF),
bioptome (TF)
Proximal CS No Failure Surgical
Extr
14F laser Yes No Success 0
8F Evolution with
outer sheath
Yes Yes Success 0
8F Evolution with
outer sheath
Yes No Success 0
12F laser Yes Yes Success 0
7F Evolution No No Success 0
12F laser No No Success 0
Mech, 14F laser,
FWS
Yes Yes Success 0
12F laser Yes No Success 0
12F laser, FWS,
gooseneck snare,
bioptome
Yes No Failure Failed Extr
at outside
hospital
16F laser No No Success 0
LLD, 14F laser CS ostium No Success 0
LLD, 14F laser CS ostium No Success 0
LLD, 12F laser No No Success 0
LLD, 12F laser Proximal CS No Success 0
9F Evolution,
Liberator
Yes Yes Success Peric
effusion
-LAT, anterolateral site; LAT, lateral site; Mech, mechanical sheath; Extr, extraction;
d locking device active-ﬁxation stylet; Peric, pericardial.
nd implant revisions are not taken into account. Deﬁnition of TLE according to HRS
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Recent experience in implantation and extraction of Starﬁx leads is
growing worldwide [13,14].
Our case conﬁrms some key points about TLE of the Starﬁx lead:
the undeployment of ﬁxation lobes, the venous occlusion, the
impossibility of conventional mechanical dilatation just beyond CS
entrance, and the effectiveness of dilatation by means of
conventional and/or modiﬁed CS delivery catheters.
To the best of our knowledge, with respect to published data,
some features of this case are unique and should be highlighted.
The dwelling time of the Starﬁx lead was 988 days, well beyond
the majority of extracted cases (only one case of the Cleveland
population was implanted 1029 days before) [8]. Our patient is the
only one in which the Starﬁx lead was located in an anterior
position, in the mid portion of the GCV. Such a distant location
increases the difﬁculty of reaching the distal tip and performing
dilatation along the lead. The progression of sheaths is even more
difﬁcult, due to the wide and almost complete curve along the
main CS, and the narrow distal angulation of the vein where it
reaches the interventricular groove.
Our case is the ﬁrst one in which the tip of the Starﬁx lead is
located in close proximity to a patent coronary artery anastomosis.
Our surgeons refused elective surgical removal of the tip, because
of its risky location, of the redo procedure, and of high surgical risk
for the patient; for the same reasons, a surgical emergency
procedure would have been prohibitive. In other cases, failure of
transvenous extraction of the Starﬁx lead was treated by urgent
surgical intervention [9].
In this case, the prior coronary artery bypass graft and
subsequent adhesion around the pericardial space might serve
as a protective factor. Pericardial adherences, indeed, mainly
protect against perforation due to counter traction maneuvers at
the tip of the lead, embedded in the myocardial ventricular and
atrial wall. The wall of CS veins is frail; therefore the risk of damage
is higher. Also, when CS is occluded along the lead, as in this case,
traction and rotational dilation forces act along a tangential vector,
and may produce long tears, rather than localized perforations.
Moreover, adherences may anelastically transmit dilation and
traction forces to the close LIMA-to-LAD anastomosis, so increasing
the risk of its damage. Conversely, adhesions can clearly make
more difﬁcult an emergency surgical reparation procedure in case
of complications.
Starﬁx lead could not have been retracted within the 7-F CS
delivery. The outer diameter of the deployed ﬁxation lobes,
expanded up to a 24-French caliber, is greater than the inner
diameter of the CS delivery (Fig. 1). The elastic recoil of these
ﬁxation lobes had not been enough to permit withdrawal within
the 7-F CS delivery, therefore resulting in entrapment of the Starﬁx
tip within the neck of the Command. Fibrosis within and around
lobes (seen in Fig. 3, Panel F) may further preclude retraction
within the Command delivery. Probably, entrapment into subcla-
vian vein of the Starﬁx tip with its undeployed lobes, strongly ﬁtted
within the distal end of the modiﬁed Command, could be
prevented by an oversized dilator, uploaded outside the Command
delivery and driven up to right atrium.
In conclusion, Starﬁx lead extraction may be challenging due
to the impossibility of undeployment of ﬁxation lobes, withincreasing difﬁculty for the frequently observed venous occlusion
around the ﬁxation mechanism. However, the transvenous
approach must always be attempted, even in presumably difﬁcult
cases, due to the long dwelling time, unfavorable and distant
anatomic location, and prohibitive surgical risk.
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